ODTC — Odonate Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $54.84m
- -$40.18m
Annual cashflow statement for Odonate, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.08 | -32.7 | -89 | -112 | -126 |
Depreciation | |||||
Non-Cash Items | 1.06 | 5 | 6.79 | 11.4 | 10.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.289 | 1.87 | 14.7 | 3.36 | 2.44 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -1.73 | -25.9 | -67.1 | -96.6 | -113 |
Capital Expenditures | 0 | -0.083 | -1.91 | -0.166 | -0.432 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | 0 | -0.083 | -1.91 | -0.166 | -0.432 |
Financing Cash Flow Items | -0.791 | 0 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 4.19 | 221 | 10.2 | 139 | 90.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.46 | 196 | -58.8 | 41.9 | -23.2 |